Last reviewed · How we verify
NCT06341010
The Role of Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
trial testing Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis in Iliofemoral Deep Vein Thrombosis in 25 participants. Currently enrolling.
1 January 2026
Quick facts
| Lead sponsor | Abdelrahman Ibrahim Sayed Mohamed Abdalla |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 1 May 2024 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
Conditions studied
- Iliofemoral Deep Vein Thrombosis — all drugs for Iliofemoral Deep Vein Thrombosis →
Sponsor
Abdelrahman Ibrahim Sayed Mohamed Abdalla
Who can join
Adults 18 to 60, any sex, with Iliofemoral Deep Vein Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the efficacy and safety of rheolytic thrombectomy in restoring venous patency DVT, periprocedural complications and development of PTS after tratment of iliofemoral DVT.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06341010
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06341010 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abdelrahman Ibrahim Sayed Mohamed Abdalla
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06341010.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing